The State Of The Psychedelic Renaissance | Shelby Hartman ~ ATTMind 211

This episode is going to explore the state of the psychedelic movement right now — the money, the policy, the ethics, and the stories that are not getting told.

Specifically, we are going to be exploring what is actually happening across the so-called psychedelic renaissance: the for-profit pharmaceutical track, city and state level decriminalization, the unregulated market selling products that mostly do not contain what they claim to, the biopiracy question that almost nobody in mainstream media will ask about, and why one of the field's most trusted journalists says psychedelics are a relationship rather than a cure. Our guest is Shelby Hartman.

What You'll Learn About:

🌊 The three waves of psychedelic research, from the 1950s through Nixon to the arrival of for-profit "corporadelic" pharma

🍄 Why almost nothing sold as a "gray market" psychedelic is legal, and what an independent lab actually found inside mushroom chocolate bars

🧭 How to vet a coach, facilitator, shaman, or space holder, and why anyone can call themselves one

🌿 Biopiracy, iboga, and the Bwiti — how plant medicine and the knowledge around it get taken without reciprocity

⚖️ Who will qualify for legal psychedelics, who can afford them, and who feels safe on a clinical couch

🔬 Whether the double-blind randomized trial is even the right design for studying psychedelics

📰 What a journalist chooses not to publish, and why not every medicine wants to be found

🌀 Episode Show Notes and other Relevant Links

📚 Check out Shelby Hartman's book The DoubleBlind Guide to Psychedelics: A Road Map to Tripping, Microdosing, and Beyond